高級檢索

頭孢菌素藥物發展和頭孢洛紮工藝開發歷程

Development of cephalosporin drugs and process of ceftolozane

  • 摘要: 在過去的50年裏,全球批準上市50多種頭孢菌素藥物,幾乎占所有批準的抗菌藥物的一半。主要闡述了抗菌藥物研發面臨的問題和抗菌藥物研發進展,並回顧了頭孢菌素合成路線變更歷程和頭孢菌素藥物歷史發展過程。頭孢洛紮是一種頭孢菌素類腸外抗生素。其硫酸鹽分子式為C23H31N12O8S2+·HSO4。與頭孢菌素類的其他成員一樣,頭孢洛紮是通過抑製青黴素結合蛋白(PBPs)發揮殺菌作用,從而抑製細胞壁合成,隨後細胞死亡。

     

    Abstract: In the past 50 years, more than fifty cephalosporin drugs have been approved worldwide, accounting for almost half of all approved antimicrobial drugs. This paper mainly expounded the problems and progress of antibacterial drug research and development, reviewed the change process of cephalosporin synthesis route and the historical development process of cephalosporin drug. Cefolozane is a parenteral antibiotic of the cephalosporin class. Ceftolozane sulfate molecular formula is C23H31N12O8S2+·HSO4. Like other members of cephalosporins, it plays a bactericidal role by inhibiting penicillin binding protein (PBPs), thereby inhibiting cell wall synthesis, and then cell death.

     

/

返回文章
返回
摩臣5娱乐专业提供:摩臣5娱乐摩臣5摩臣5平台等服务,提供最新官网平台、地址、注册、登陆、登录、入口、全站、网站、网页、网址、娱乐、手机版、app、下载、欧洲杯、欧冠、nba、世界杯、英超等,界面美观优质完美,安全稳定,服务一流,摩臣5娱乐欢迎您。 摩臣5娱乐官網xml地圖